The paper titled "Post-acute cardiovascular manifestations of COVID-19: Risk and burden" investigates the cardiovascular consequences following acute coronavirus disease 2019 (COVID-19) infection. The researchers utilized national healthcare databases from the US Department of Veterans Affairs to analyze a cohort of 153,760 individuals with COVID-19, along with two control groups comprising 5,637,647 contemporary controls and 5,859,411 historical controls. Their objective was to estimate the risks and 1-year burdens of various incident cardiovascular outcomes.
The study reveals that beyond the initial 30 days after COVID-19 infection, individuals remain at an elevated risk of developing several types of cardiovascular diseases. These include cerebrovascular disorders, dysrhythmias, both ischemic and non-ischemic heart disease, pericarditis, myocarditis, heart failure, and thromboembolic disease. Notably, these risks and burdens are observed not only in hospitalized patients but also in those who were not hospitalized during the acute phase of the infection. The study further indicates that the risks escalate based on the severity of care needed during the acute phase, categorized as non-hospitalized, hospitalized, or admitted to intensive care.
The findings underscore the substantial risk and long-term burden of cardiovascular disease among survivors of acute COVID-19. Consequently, the study emphasizes the importance of integrating cardiovascular health and disease management into the care pathways of individuals who have recovered from the acute phase of COVID-19.
Overall, this research highlights the significant cardiovascular implications of COVID-19 beyond the acute phase, calling for heightened attention to cardiovascular health in COVID-19 survivors and the inclusion of appropriate measures for cardiovascular disease prevention and management in their post-acute care. Read more at ....https://www.nature.com/articles/s41591-022-01689-3